Danaher Appoints Julie Sawyer Montgomery as President and CEO

Management
โดย PR Newswire·Read original
Summary · why it matters

Danaher Corporation has appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026. She succeeds Rainer Blair, who will retire and serve as a senior advisor until March 31, 2027 to ensure a seamless transition. Ms. Sawyer Montgomery joined Danaher in 2017 and helped grow the Diagnostics platform from approximately $6.0 billion in revenue to approximately $11.0 billion today, while approximately tripling operating profit. She most recently served as Executive Vice President with responsibility for the Diagnostics platform. The company also announced special equity incentive awards for key leadership members and founders, and stated there is no change to its previously communicated third quarter and full-year 2026 guidance.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Danaher Corporation
DHR
± MixedCapitalrelevance

CEO transition and equity awards; guidance unchanged, impact unclear.